{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:37:10Z","timestamp":1772768230376,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.virusres.2021.198527","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T13:08:23Z","timestamp":1627650503000},"page":"198527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Adenovirus type 5 vectors encoding short hairpin RNAs targeting dengue virus 5\u2019 non-translated region and capsid gene suppress pre-established dengue infection in cultured epithelial and myeloid cells"],"prefix":"10.1016","volume":"304","author":[{"given":"Hemalatha","family":"Beesetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathyamangalam","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2021.198527_bib0001","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.02696-06","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D","volume":"81","author":"Abbink","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2021.198527_bib0002","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1128\/JVI.79.11.6631-6643.2005","article-title":"Long-range RNA-RNA interactions circularize the dengue virus genome","volume":"79","author":"Alvarez","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2021.198527_bib0003","doi-asserted-by":"crossref","first-page":"12110","DOI":"10.1073\/pnas.0705474104","article-title":"Stable reduction of CCR5 by RNAi through hematopoietic stem cells transplant in non-human primates","volume":"104","author":"An","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virusres.2021.198527_bib0005","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2021.198527_bib0006","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","article-title":"The role of IgG Fc receptors in antibody-dependent enhancement","volume":"20","author":"Bournazos","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virusres.2021.198527_bib0007","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1128\/JVI.80.5.2170-2182.2006","article-title":"RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication","volume":"80","author":"Clyde","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2021.198527_bib0008","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.gt.3302656","article-title":"Induction of stable RNA interference in mammalian cells","volume":"13","author":"Cullen","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2021.198527_bib0009","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gad.1064703","article-title":"siRNAs can function as miRNAs","volume":"17","author":"Doench","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.virusres.2021.198527_bib0010","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/JVI.75.1.480-489.2001","article-title":"Functional and selective targeting of adenovirus to high-affinity Fcg receptor I-positive cells by using a bispecific hybrid adapter","volume":"75","author":"Ebbinghaus","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2021.198527_bib0011","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/v12091044","article-title":"Generation of combinatorial lentiviral vectors expressing multiple anti-hepatitis C virus shRNAs and their validation on a novel HCV replicon double reporter cell line","volume":"12","author":"Elbadawy","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2021.198527_bib0004","unstructured":"ATCC FAQ's, 2021. Is it possible to determine from the TCID[50] how many plaque forming units to expect? Available at https:\/\/www.atcc.org\/support\/technical-support\/faqs\/converting-tcid-50-to-plaque-forming-units-pfu (accessed Aug 05, 2021)."},{"key":"10.1016\/j.virusres.2021.198527_bib0012","unstructured":"EMA, 2018. EMA\/CHMP\/510214\/2018. New medicine for hereditary rare disease. Available at https:\/\/www.ema.europa.eu\/documents\/press-release\/new-medicine-hereditary-rare-disease_en-0.pdf (accessed Jun 23, 2021)."},{"key":"10.1016\/j.virusres.2021.198527_bib0013","unstructured":"EMA, 2020a. EMA\/CHMP\/46675\/2020. First treatment for acute hepatic porphyria. Available at https:\/\/www.ema.europa.eu\/en\/documents\/press-release\/first-treatment-acute-hepatic-porphyria_en.pdf (accessed Jun 23, 2021)."},{"key":"10.1016\/j.virusres.2021.198527_bib0014","unstructured":"EMA, 2020b. EMA\/CHMP\/520993\/2020. Available at https:\/\/www.ema.europa.eu\/en\/documents\/smop-initial\/chmp-summary-positive-opinion-leqvio_en.pdf (accessed Jun 23, 2021)."},{"key":"10.1016\/j.virusres.2021.198527_bib0015","unstructured":"EMA, 2020c. EMA\/CHMP\/529305\/202. Available at https:\/\/www.ema.europa.eu\/en\/documents\/smop-initial\/chmp-summary-positive-opinion-oxlumo_en.pdf (accessed Jun 23, 2021)."},{"key":"10.1016\/j.virusres.2021.198527_bib0016","unstructured":"FDA, 2018. FDA approves first-of-its-kind targeted RNA-based therapy to treat a rare disease. Available at https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-its-kind-targeted-rna-based-therapy-treat-rare-disease (accessed Jun 23, 2021)."},{"key":"10.1016\/j.virusres.2021.198527_bib0017","unstructured":"FDA, 2019. FDA approves first treatment for inherited rare disease. Available at https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-inherited-rare-disease#:\u223c:text=Today%2C (accessed Jun 23, 2021)."},{"key":"10.1016\/j.virusres.2021.198527_bib0018","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/14760584.2017.1335201","article-title":"A recombinant live attenuated tetravalent vaccine for the prevention of dengue","volume":"16","author":"Guy","year":"2017","journal-title":"Expert Rev. Vaccine"},{"key":"10.1016\/j.virusres.2021.198527_bib0019","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virusres.2021.198527_bib0020","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4269\/ajtmh.1982.31.830","article-title":"Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence","volume":"31","author":"Henchal","year":"1982","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virusres.2021.198527_bib0021","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1016\/j.vaccine.2009.07.073","article-title":"An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity","volume":"27","author":"Khanam","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2021.198527_bib0022","doi-asserted-by":"crossref","first-page":"e1735","DOI":"10.1371\/journal.pntd.0001735","article-title":"Adenovirus delivered short hairpin RNA targeting a conserved site in the 5\u2019 non-translated region inhibits all four DENV serotypes of dengue viruses","volume":"6","author":"Korrapati","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virusres.2021.198527_bib0023","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/JCM.00827-07","article-title":"Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization","volume":"45","author":"Kraus","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virusres.2021.198527_bib0024","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/jcm.30.3.545-551.1992","article-title":"Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction","volume":"30","author":"Lanciotti","year":"1992","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virusres.2021.198527_bib0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12250-020-00230-5","article-title":"On the calculation of TCID50 for quantitation of virus infectivity","volume":"36","author":"Lei","year":"2021","journal-title":"Virol Sinica"},{"key":"10.1016\/j.virusres.2021.198527_bib0026","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1128\/JVI.00512-06","article-title":"Neutralized adenovirus-immune complexes can mediate effective gene transfer via an Fc receptor-dependent infection pathway","volume":"80","author":"Leopold","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2021.198527_bib0027","series-title":"Fields Virology","first-page":"712","article-title":"Flaviviridae","author":"Lindenbach","year":"2013"},{"key":"10.1016\/j.virusres.2021.198527_bib0028","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/v12090924","article-title":"Viral vectors applied for RNAi-based antiviral therapy","volume":"12","author":"Lundstrom","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2021.198527_bib0029","first-page":"299","article-title":"The RNA secondary structural variation in the cyclization elements of the dengue genome and the possible implications in pathogenicity","volume":"31","author":"Mishra","year":"2020","journal-title":"Virus Dis."},{"key":"10.1016\/j.virusres.2021.198527_bib0030","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cell.2006.01.040","article-title":"A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen","volume":"124","author":"Moffat","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.virusres.2021.198527_bib0031","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.virusres.2018.11.014","article-title":"Inhibition of dengue virus replication in monocyte-derived dendritic cells by vivo-morpholino oligomers","volume":"260","author":"Phumesin","year":"2019","journal-title":"Virus Res."},{"key":"10.1016\/j.virusres.2021.198527_bib0032","series-title":"Fields Virology","first-page":"747","article-title":"Flaviviruses","author":"Pierson","year":"2013"},{"key":"10.1016\/j.virusres.2021.198527_bib0033","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/jmv.21721","article-title":"The prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccines","volume":"82","author":"Pilankatta","year":"2010","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2021.198527_bib0034","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1073\/pnas.232688199","article-title":"Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5","volume":"100","author":"Qin","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.virusres.2021.198527_bib0035","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3389\/fimmu.2014.00647","article-title":"Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity","volume":"5","author":"Schmid","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virusres.2021.198527_bib0036","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Disc."},{"key":"10.1016\/j.virusres.2021.198527_bib0037","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1128\/JVI.02105-08","article-title":"Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production","volume":"84","author":"Subramanya","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2021.198527_bib0038","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1128\/JVI.77.15.8263-8271.2003","article-title":"Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity","volume":"77","author":"Vogels","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2021.198527_bib0039","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Deliv."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170221002343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170221002343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:13:50Z","timestamp":1759155230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170221002343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"alternative-id":["S0168170221002343"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2021.198527","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenovirus type 5 vectors encoding short hairpin RNAs targeting dengue virus 5\u2019 non-translated region and capsid gene suppress pre-established dengue infection in cultured epithelial and myeloid cells","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2021.198527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"198527"}}